Truveris is a digital health company that partners with employers, brokers, and pharmaceutical companies to dramatically improve people’s ability to afford and access prescription drugs. With expertise and technology solutions that span across the prescription drug ecosystem, we deliver the outcomes people and businesses need to thrive.
We are on a mission to transform the pharmacy benefit industry and are backed by leading venture capital firms including Canaan Partners, First Round, New Atlantic Ventures, New Leaf Venture Partners, Tribeca Venture Partners and McKesson Ventures. In 2018, Truveris was ranked as one of the fastest growing technology companies in the U.S. by Deloitte, Crain's, and Inc.
Truveris has no open listings at this time.